Showing results (891-900 of 2,539) with videos related to
Sort By:
Pageof 254
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti|July 21, 2006
[Primary non-Hodgkin orbital lymphoma: case report]Sanda Rozanković, Renata Iveković, Katia Novak-Laus, et al.Frontiers in Neuroscience|December 19, 2022
Tackling the challenges of group network inference from intracranial EEG dataAnna Pidnebesna, Pavel Sanda, Adam Kalina, et al.The Journal of Urology|August 23, 2000
Prospective assessment of patient reported urinary continence after radical prostatectomyJ T Wei, R L Dunn, R Marcovich, et al.Acta Obstetricia Et Gynecologica Scandinavica|February 11, 2011
Prevalence and risk factors for anal incontinence after obstetric anal sphincter ruptureKatariina Laine, Finn Egil Skjeldestad, Birgitte Sanda, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosisMaria Pia Sormani, Bettina Stubinski, Peter Cornelisse, et al.International Journal of Biological Macromolecules|May 29, 2012
Flavonoid aglycones can compete with Ochratoxin A for human serum albumin: a new possible mode of actionMiklós Poór, Sándor Kunsági-Máté, Tímea Bencsik, et al.Urology|February 5, 2008
Lower limits of detection using magnetic resonance imaging for solid components in cystic renal neoplasmsGregory S Adey, Ivan Pedrosa, Neil M Rofsky, et al.Journal of Pediatric Endocrinology & Metabolism : JPEM|December 7, 2007
Ghrelin serum levels during oral glucose tolerance test in prepubertal obese children with insulin resistanceAssimina Galli-Tsinopoulou, Charilaos Stylianou, Dimitrios Farmakiotis, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 11, 2007
Adiponectin and body composition in cystic fibrosisParaskevi Panagopoulou, Maria Fotoulaki, Alexandros Manolitsas, et al.Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
Baseline Serum Metabolites as Predictors of Teplizumab Response in Individuals with Type 1 DiabetesElizabeth R Flammer, Lauren E Higdon, Srinath Sanda, et al.Pageof 254